View Single Post
  #2  
Old Sat Nov 12, 2011, 04:11 PM
Darice Darice is offline
Member
 
Join Date: Jun 2011
Location: Colorado Springs, CO
Posts: 91
prognostic models for t-MDS

Interesting . . . eager to read more, but it seems to consider more factors than the MDAnderson model. Both point up some of the differences between dealing with de novo and therapy-related MDS . . . which the IPSS doesn't differentiate. Here's a link to the MD Anderson study:

http://onlinelibrary.wiley.com/doi/1...ncr.23697/full

Sometimes I wonder whether I really want to read more or not. Gets discouraging . . . but I see that this needs to be considered in choosing treatment.
__________________
hubby 73, dx NHL 2001, CNS involvement. SCT (auto) 5/08 [dx UTUC renal pelvis, 2010/surgeries/MMC], MANY recurrences, chemos, surgeries, rad. dx t-MDS 3/11: IPSS 1.5 (Int-2); MDA 11, RCMD trilineage, inc. Fe, ring sideroblasts, 7q del/mono 7 (51.5%), 46,XY,t(6,17)(p22;q25)[4]/45,XY,-7[4]/46,XY[12].
Reply With Quote